Gemcitabine, cisplatin and vinorelbine as induction chemotherapy followed by radical therapy in stage III non-small-cell lung cancer: A multicentre study of galician-lung-cancer-group

Lung Cancer

Volumn 40, Issue 2, 2003, Pages 215-220

  León, Luis ^a   Cueva Banuelos, Juan F ^b,i   Huidobro, G ^c   Firvida J L ^d   Amenedo, M ^e   Lazaro M ^f   Romero, C ^g   Estevez S V ^h   Baron F J ^b   Grande, C ^c   Garcia Mata J ^d   Gonzalez A ^e   Castellanos, J ^f   Gomez A ^b   Caeiro, M ^c   Rodriguez M R ^d   Casal, J ^c  

^a Data Manager Galician Lung Cancer G   (Spain)

^b Instituto de Salud Carlos III   (Spain)

^c HOSPITAL DO MEIXOEIRO   (Spain)

^d Hospital Santa Maria Nai   (Spain)

^e Centro Oncologico de Galicia   (Spain)

^f HOSPITAL XERAL CÍES   (Spain)

^g Department of Medical Oncology ^*  (Spain)

^h HOSPITAL XERAL CALDE   (Spain)

ⁱ Hospital Clínico   (Spain)

Author keywords

Cisplatin; Gemcitabine; Non small cell lung cancer; Vinorelbine

Indexed keywords

AMINOTRANSFERASE; CISPLATIN; CREATININE; GEMCITABINE; HEMOGLOBIN; NAVELBINE;

ADULT; ALOPECIA; ANEMIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISEASE SEVERITY; DRUG EFFICACY; DRUG FATALITY; DRUG TOXICITY; DYSPNEA; FATIGUE; FEBRILE NEUTROPENIA; FEMALE; HEART FAILURE; HUMAN; HUMAN TISSUE; LIVER TOXICITY; LUNG NON SMALL CELL CANCER; LUNG RESECTION; MALE; MULTICENTER STUDY; NAUSEA; NEPHROTOXICITY; NEUROPATHY; NEUTROPENIA; NEUTROPHIL; PATIENT SELECTION; PNEUMONIA; PRIORITY JOURNAL; SHOCK; STOMATITIS; THROMBOCYTE; THROMBOCYTOPENIA; VOMITING;

EID: 0037404115     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(03)00030-8     Document Type: Article

References (27)

1. Ihde D.C. Chemotherapy of lung cancer. New Engl. J. Med. 327:1992;1434-1441.
2. Rosell R., Gómez Codina J., Camps C., et al. A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small cell lung cancer. New Engl. J. Med. 330:1994;153-158.
3. Roth J.A., Fossella F., Komaki R., et al. A randomized trial comparing preoperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small cell lung cancer. J. Natl. Cancer Inst. 86:1994;673-680.
4. Thatcher N., Ranson M., Lee S.M., Niven R., Anderson H. Chemotherapy in non-small cell lung cancer. Ann. Oncol. 6:(Suppl. 1):1995;S83-S85.
5. Clinical practice guidelines for the treatment of unresectable non-small-cell lung cancer. J. Clin. Oncol. 15:1997;2996-3018. special article.
6. Grilli R., Oxman A.D., Julian J.A. Chemotherapy for advanced non-small cell lung cancer: how much benefit is enough. J. Clin. Oncol. 11:1993;1866-1872.
7. Marino P., Pampallona S., Preatoni A., Invernizzi F. Chemotherapy versus supportive care in advanced non-small cell lung cancer: results of a meta-analysis of the literature. Chest. 106:1994;861-865.
8. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomized clinical trials. Br. Med. J. 311:1995;899-909.
9. Schiller J.H., Harrington D., Belani C., et al. Comparison of four chemotherapy regimens for advanced non-small cell lung cancer. New Engl. J. Med. 346:2002;92-98.
10. Crinó L., Scagliotti G.V., Ricci S., et al. Gemcitabine and cisplatin versus mitomycin, ifosfamide, and cisplatin in advanced non-small-cell lung cancer: a randomized phase III study of the Italian Lung Cancer Project. J. Clin. Oncol. 17:1999;3522-3530.
11. Sandler A.B., Nemunaitis J., Denham C., et al. Phase III trial of gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non-small-cell-lung-cancer. J. Clin. Oncol. 18:2000;122-130.
12. Cardenal F., Lopez-Cabrerizo M., Anton A., et al. Randomized phase III study of gemcitabine-cisplatin versus etoposide-cisplatin in the treatment of locally advanced or metastatic non-small-cell lung cancer. J. Clin. Oncol. 17:1999;12-18.
13. Wozniak A.J., Crowley J.J., Balcerzak S.P., et al. Randomized trial comparing cisplatin with cisplatin plus vinorelbine in the treatment of advanced non-small-cell lung cancer: a Southwest Oncology Group Study. J. Clin. Oncol. 16:1998;2459-2465.
14. Kelly K., Crowley J., Bunn P.A. Jr, et al. Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non-small-cell lung cancer: A Southwest Oncology Group Trial. J. Clin. Oncol. 19:2001;3210-3218.
15. Le Chevalier T., Brisgand D., Douillard J.Y., et al. Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small cell lung cancer: results of a European Multicenter Trial including 612 patients. J. Clin. Oncol. 12:1994;360-366.
16. Le Chevalier T., Brisgand D., Soria J.C., et al. Long term analysis of survival in the European Randomized Trial comparing vinorelbine/cisplatin to vindesine/cisplatin and vinorelbine alone in advanced non-small cell lung cancer. Oncologist. 6:(Suppl. 1):2001;8-11.
17. Frasci G., Panza N., Comella P., et al. Cisplatin, gemcitabine and vinorelbine in locally advanced or metastatic non-small cell lung cancer. Ann. Oncol. 8:1997;1045-1048.
18. Peters G.J., Bergman A.M., Ruiz van Haperen V.W.T., Veerman G., Kuiper C.M., Braakhuis B.J.M. Interaction between cisplatin and gemcitabine in vitro and in vivo. Semin. Oncol. 22:(4, Suppl. 11):1995;72-79.
19. Van Moorsel C.J.A., Veerman G., Bergman A.M., et al. Combination chemotherapy studies with gemcitabine. Semin. Oncol. 24:(Suppl. 7):1997;S717-S723.
20. Cartei G., Sacco C., Sibau A., Pella N., Iop A., Tabaro G. Cisplatin and gemcitabine in non-small-cell lung cancer. Anna. Oncol. 10:(Suppl. 5):1999;S57-S62.
21. Comella P., Frasci G., Panza N., et al. Cisplatin, gemcitabine, and vinorelbine combination therapy in advanced non-small-cell lung cancer (NSCLC): a phase II randomized study of the Southern Italy Cooperative Oncology Group. J. Clin. Oncol. 17:1999;1525-1534.
22. Comella P., Frasci G., Panza N., et al. Randomized trial comparing cisplatin, gemcitabine and vinorelbine with either cisplatin and gemcitabine or cisplatin or cisplatin and vinorelbine in advanced non-small-cell lung cancer: interim analysis of a phase III trial of the Southern Italy Cooperative Oncology Group. J. Clin. Oncol. 18:2000;1451-1457.
23. Comella P. Phase III trial of cisplatin/gemcitabine with or without vinorelbine or paclitaxel in advanced non-small cell lung cancer. Semin. Oncol. 28:(Suppl. 7):2001;7-10.
24. Ginopoulos P., Mastronikolis N.S., Giannios J., et al. A phase II study with vinorelbine, gemcitabine and cisplatin in the treatment of patients with stage IIIb-IV non-small cell lung cancer (NSCLC). Lung Cancer. 23:1999;31-37.
25. Alberola V., Camps C., Provencia M., et al. Cisplatin/gemcitabine (CG) vs. cisplatin/gemcitabine/vinorelbine (CGV) vs. sequential doublets of gemcitabine/vinorelbine followed by ifosfamide/vinorelbine (GV/IV) in advanced non-small cell lung cancer (NSCLC): results of a Spanish Lung Cancer Group phase III trial (GECP/98-02). Proc. Am. Soc. Clin. Oncol. 308a:2001;1229. abstract.
26. Rinaldi M., Crinò L. Induction chemotherapy with gemcitabine and cisplatin in stage III non-small cell lung cancer. Lung Cancer. 34:2001;S25-S30.
27. Van Zandwijk N., Smit E.F., Kramer G.W.P., et al. Gemcitabine and cisplatin as induction regimen for patients with biopsy proven stage III non-small-cell-lung-cancer: a phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group (EORTC 08955). J. Clin. Oncol. 18:2000;2658-2664.